{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T16:36:39Z","timestamp":1768840599561,"version":"3.49.0"},"reference-count":31,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2024,1,2]]},"DOI":"10.1080\/14740338.2023.2293207","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T07:47:48Z","timestamp":1703144868000},"page":"79-88","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Safety and effectiveness of rasagiline in patients with Parkinson\u2019s disease in Japan: a post-marketing surveillance study"],"prefix":"10.1080","volume":"23","author":[{"given":"Nobutaka","family":"Hattori","sequence":"first","affiliation":[{"name":"Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Kajita","sequence":"additional","affiliation":[{"name":"Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Izutsu","sequence":"additional","affiliation":[{"name":"Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovelle","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"e_1_3_7_4_1","volume-title":"Madame Curie Bioscience Database","author":"Triarhou LC","year":"2000","unstructured":"Triarhou LC. Dopamine and Parkinson\u2019s disease. In: Madame Curie Bioscience Database Internet. Austin (TX): Landes Bioscience; 2000\u20132013. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK6271\/"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.776847"},{"issue":"11","key":"e_1_3_7_6_1","first-page":"939","article-title":"Parkinson\u2019s disease collaborators. Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global burden of disease study 2016","volume":"17","author":"GBD","year":"2016","unstructured":"GBD. Parkinson\u2019s disease collaborators. Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global burden of disease study 2016. Lancet Neurol. 2016;17(11):939\u2013953.","journal-title":"Lancet Neurol"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.s12160420"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1134472"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S139545"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.12.1937"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809335"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.2.241"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71083-7"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.08.024"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.04.025"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/00207451003778744"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-018-1964-3"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-018-1962-5"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2011.573784"},{"key":"e_1_3_7_21_1","volume-title":"Tablets for oral use [package insert]","author":"AZILECT\u00ae (rasagiline mesylate)","year":"2022","unstructured":"AZILECT\u00ae (rasagiline mesylate). Tablets for oral use [package insert]. Tokyo. Japan: Takeda Pharmaceutical Company Limited; 2022. Japanese."},{"key":"e_1_3_7_22_1","volume-title":"[Package insert]","author":"AZILECT\u00ae (rasagiline tablets)","year":"2014","unstructured":"AZILECT\u00ae (rasagiline tablets). [Package insert]. North (UK PA): TEVA Pharmaceuticals USA, Inc.; 2014."},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.02986.x"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.baga.2015.09.003"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000210692.95595.1c"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03484.x"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.790956"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006737"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2017.1293285"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4216452"},{"key":"e_1_3_7_31_1","first-page":"153\u2013163, 293","volume-title":"Recent developments in Parkinson\u2019s disease","author":"Fahn S","year":"1987","unstructured":"Fahn S, Elton R. Members of the UPDRS development committee. The Unified Parkinson\u2019s disease Rating scale. In: Fahn S, Marsden C Calne D, et al. Eds. Recent developments in Parkinson\u2019s disease. Vol. 2. Florham Park (NJ): Macmillan Health Care Information; 1987. p. 153\u2013163, 293\u2013304."},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21198"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2293207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T17:38:57Z","timestamp":1727199537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2293207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,2]]}},"alternative-id":["10.1080\/14740338.2023.2293207"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2293207","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}